The LONG BOW system is the first interbody on the market that expands laterally in-situ specifically for a direct lateral approach. Surgeons can decrease the amount of retraction by as much as 45 percent when compared with other lateral systems, said Vice President of Business Development and Professional Relations Richard Greiber.
“The benefits of LONG BOW are transferred directly to the patient by minimizing tissue retraction and potential nerve damage associated with the lateral access approach,” he said.
More articles on orthopedic devices:
Orthofix appoints Luke Faulstick to board of directors
Orchid Orthopedic Solutions gets $10k Facilities Tax Exemption—5 things to know
Ortho Development celebrates 20th anniversary
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
